Onis Onxeo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onis onxeo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onis Onxeo Today - Breaking & Trending Today

Onxeo S.A.: Onxeo: Combined General Meeting of June 6, 2023: Availability of Preparatory Documents and Participation & Voting Procedures

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and ....

France General , Onxeo Sa Euronext , Onis Onxeo , Arthur Rouill , Nicolas Fossiez , Gewinn Nur , Raymond Poincar , Renaissance Paris Nobel Tour Eiffel Hotel , Company Group , Regulatory News , Euronext Growth Paris , Combined General Meeting , General Meeting , General Meetings , Investor Relations ,

Onxeo S.A.: Onxeo will publish its full-year results on April 24, 2023

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and ....

France General , Onxeo Sa Euronext , Onis Onxeo , Nicolas Fossiez , Arthur Rouill , Company Group , Regulatory News , Euronext Growth Paris , Monday April ,

Onxeo Will Publish Its Full-year Results on April 21, 2023

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX) (Paris:ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response ....

France General , Onis Onxeo , Arthur Rouill , Nicolas Fossiez , Onxeo Sa Euronext , Company Group , Regulatory News , Euronext Growth Paris ,

Onxeo Will Publish Its Full-year Results on April 14, 2023

The annual general meeting will be held on June 6, 2023 Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX) (Paris:ALONX), a clinical-stage biotechnology company specializing in the development ....

France General , Dennis Riedl , Arthur Rouill , Onis Onxeo , Nicolas Fossiez , Onxeo Sa Euronext , Company Board Of Directors , Company Group , Euronext Growth Paris ,

Onxeo S.A.: Onxeo: Report on the Extraordinary General Meeting of February 6, 2023

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), ("Onxeo" or "the Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor ....

France General , Arthur Rouill , Onis Onxeo , Nicolas Fossiez , Onxeo Sa Euronext , Schwierige Zeiten , Company Group , Regulatory News , Euronext Growth Paris , Extraordinary General Meeting , General Meeting , General Meetings ,